Search

Your search keyword '"Reifenberger, A."' showing total 354 results

Search Constraints

Start Over You searched for: Author "Reifenberger, A." Remove constraint Author: "Reifenberger, A." Topic biology Remove constraint Topic: biology
354 results on '"Reifenberger, A."'

Search Results

1. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

2. Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas

3. A common classification framework for histone sequence alterations in tumours: an expert consensus proposal

4. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

5. A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

6. Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype

7. Sellar region atypical teratoid/rhabdoid tumors (ATRT) in adults display DNA methylation profiles of the ATRT-MYC subgroup

8. Pan-cancer analysis of whole genomes

9. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults

10. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

11. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

12. Sex differences in oncogenic mutational processes

13. The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen

14. The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells

15. Longitudinal molecular trajectories of diffuse glioma in adults

16. Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion

17. Distribution of GOPC:ROS1 and other ROS1 fusions in glioma types

18. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial ependymoma

19. The presence of TIM‐3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status

20. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification

21. Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma

22. Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells

23. The molecular evolution of glioblastoma treated by gross total resection alone

24. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?

25. 4EBP1/2 are active under standard cell culture conditions to regulate the translation of specific mRNAs

26. A subset of pediatric thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

27. Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies

28. Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity

29. 3D Printing-Enabled DNA Extraction for Long-Read Genomics

30. The landscape of genomic alterations across childhood cancers

31. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET

32. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma

33. A PRDX1-p38α heterodimer amplifies MET-driven invasion ofIDH-wildtype andIDH-mutant gliomas

34. Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses

35. Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas

36. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma

37. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations

38. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors

39. OC-0322: 4-miRNA signature and MGMT promoter methylation improve risk stratification in glioblastoma

40. Molecular targeted therapy of glioblastoma

41. FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas

42. MEDU-20. HDAC AND NFκB ANTAGONISTS SYNERGISTICALLY INHIBIT GROWTH OF MYC-DRIVEN MEDULLOBLASTOMA

43. BIOL-02. CELLULAR HETEROGENEITY CONTRIBUTES TO THE AGGRESSIVE BEHAVIOR OF MYC-DRIVEN MEDULLOBLASTOMA

44. SIG-03. HHIP-AS1 PROMOTES TUMOR SURVIVAL THROUGH STABILIZING DYNEIN COMPLEX 1 IN HEDGEHOG DRIVEN HUMAN BRAIN TUMORS

45. RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas

46. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA

47. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

48. EMBR-13. NOVEL SYNERGISTIC APPROACHES FOR TARGETED THERAPY OF MYC-DRIVEN MEDULLOBLASTOMA USING CRISPR/CAS9 GENE EDITING

49. Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel

50. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Catalog

Books, media, physical & digital resources